Impact of new oral or intravenous P2Y12 inhibitors and clopidogrel on major ischemic and bleeding events in patients with coronary artery disease: a meta-analysis of randomized trials. [electronic resource]
Producer: 20141211Description: 568-578 p. digitalISSN:- 1879-1484
- Acute Coronary Syndrome -- epidemiology
- Adenosine -- administration & dosage
- Adenosine Monophosphate -- administration & dosage
- Administration, Oral
- Clopidogrel
- Coronary Artery Disease -- complications
- Coronary Restenosis -- prevention & control
- Fibrinolytic Agents -- adverse effects
- Hemorrhage -- chemically induced
- Humans
- Injections, Intravenous
- Multicenter Studies as Topic -- statistics & numerical data
- Myocardial Infarction -- epidemiology
- Piperazines -- administration & dosage
- Prasugrel Hydrochloride
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Quinazolinones -- administration & dosage
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Stents
- Stroke -- epidemiology
- Sulfonamides -- administration & dosage
- Thiophenes -- administration & dosage
- Thrombolytic Therapy -- adverse effects
- Ticagrelor
- Ticlopidine -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.